Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 50

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications

Youssef, Amr A., Ross, Elsie Gyang, Bolli, Roberto, Pepine, Carl J., Leeper, Nicholas J., Yang, Phillip C. · 2016 · JACC: Basic to Translational Science

Abstract

The recent discovery of human-induced pluripotent stem cells (iPSCs) has revolutionized the field of stem cells. iPSCs have demonstrated that biological development is not an irreversible process and that mature adult somatic cells can be induced to become pluripotent. This breakthrough is projected to advance our current understanding of many disease processes and revolutionize the approach to effective therapeutics. Despite the great promise of iPSCs, many translational challenges still remain. In this article, we review the basic concept of induction of pluripotency as a novel approach to understand cardiac regeneration, cardiovascular disease modeling and drug discovery. We critically reflect on the current results of preclinical and clinical studies using iPSCs for these applications with appropriate emphasis on the challenges facing clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacbts.2016.06.010

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 125

  1. Briggs, 1952, Transplantation of living nuclei from blastula cells into enucleated frogs’ eggs, Proc Natl Acad Sci U S A, 38, 455, 10.1073/pnas.38.5.455 · DOI · Paper page
  2. Gurdon, 1958, Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei, Nature, 182, 64, 10.1038/182064a0 · DOI · Paper page
  3. Cowan, 2005, Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells, Science, 309, 1369, 10.1126/science.1116447 · DOI · Paper page
  4. Tada, 2001, Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells, Curr Biol, 11, 1553, 10.1016/S0960-9822(01)00459-6 · DOI · Paper page
  5. Hochedlinger, 2006, Nuclear reprogramming and pluripotency, Nature, 441, 1061, 10.1038/nature04955 · DOI · Paper page
  6. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  7. Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 · DOI · Paper page
  8. Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
  9. Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
  10. Wernig, 2007, In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state, Nature, 448, 318, 10.1038/nature05944 · DOI · Paper page
  11. Park, 2008, Reprogramming of human somatic cells to pluripotency with defined factors, Nature, 451, 141, 10.1038/nature06534 · DOI · Paper page
  12. Aasen, 2008, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes, Nat Biotechnol, 26, 1276, 10.1038/nbt.1503 · DOI · Paper page
  13. Brown, 2010, Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes, PLoS One, 5, e11373, 10.1371/journal.pone.0011373 · DOI · Paper page
  14. Giorgetti, 2009, Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2, Cell Stem Cell, 5, 353, 10.1016/j.stem.2009.09.008 · DOI · Paper page
  15. Ge, 2012, Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells, Stem Cells Dev, 21, 2798, 10.1089/scd.2011.0435 · DOI
  16. Kim, 2009, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 649, 10.1038/nature08436 · DOI · Paper page
  17. Sun, 2009, Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells, Proc Natl Acad Sci U S A, 106, 15720, 10.1073/pnas.0908450106 · DOI · Paper page
  18. Zhou, 2012, Generation of human induced pluripotent stem cells from urine samples, Nat Protoc, 7, 2080, 10.1038/nprot.2012.115 · DOI · Paper page
  19. Mauritz, 2008, Generation of functional murine cardiac myocytes from induced pluripotent stem cells, Circulation, 118, 507, 10.1161/CIRCULATIONAHA.108.778795 · DOI · Paper page
  20. Narazaki, 2008, Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells, Circulation, 118, 498, 10.1161/CIRCULATIONAHA.108.769562 · DOI · Paper page
  21. Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29
  22. Xiong, 2013, Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling, Circulation, 127, 997, 10.1161/CIRCULATIONAHA.112.000641 · DOI
  23. Li, 2013, Intramyocardial injection of pig pluripotent stem cells improves left ventricular function and perfusion: a study in a porcine model of acute myocardial infarction, PLoS One, 8, e66688, 10.1371/journal.pone.0066688 · doi:10.1371/journal.pone.0066688
  24. Sanchez-Freire, 2014, Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells, J Am Coll Cardiol, 64, 436, 10.1016/j.jacc.2014.04.056 · DOI
  25. Kamao, 2014, Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application, Stem Cell Reports, 2, 205, 10.1016/j.stemcr.2013.12.007 · DOI · Paper page
  26. Sanchez Alvarado, 2014, Rethinking differentiation: stem cells, regeneration, and plasticity, Cell, 157, 110, 10.1016/j.cell.2014.02.041 · DOI · Paper page
  27. Ko, 2014, Concise review: drug discovery in the age of the induced pluripotent stem cell, Stem Cells Transl Med, 3, 500, 10.5966/sctm.2013-0162 · DOI
  28. Lalit, 2014, Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges, Circ Res, 114, 1328, 10.1161/CIRCRESAHA.114.300556 · DOI
  29. Nelson, 2009, Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells, Circulation, 120, 408, 10.1161/CIRCULATIONAHA.109.865154 · DOI · Paper page
  30. Ahmed, 2011, Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction, Regen Med, 6, 171, 10.2217/rme.10.103 · DOI
  31. Kim, 2015, Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium, Circ Res, 116, e40, 10.1161/CIRCRESAHA.116.304668 · DOI
  32. Zhang, 2011, Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart, PLoS One, 6, e19012, 10.1371/journal.pone.0019012 · DOI
  33. Nussbaum, 2007, Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response, FASEB J, 21, 1345, 10.1096/fj.06-6769com · DOI · Paper page
  34. Arai, 2006, Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 T, Magn Reson Med, 55, 203, 10.1002/mrm.20702 · DOI
  35. Ahmed, 2011, Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart, Circ Res, 109, 60, 10.1161/CIRCRESAHA.110.240010 · DOI
  36. Buccini, 2012, Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart, Basic Res Cardiol, 107, 301, 10.1007/s00395-012-0301-5 · DOI
  37. Rulifson, 2014, Abstract 19831: in vivo molecular imaging of human pluripotent stem cell-derived cardiomyocytes in a murine myocardial injury model via a safe harbor integration of a reporter gene, Circulation, 130, A19831, 10.1161/circ.130.suppl_2.19831 · doi:10.1161/circ.130.suppl_2.19831
  38. Pasha, 2011, Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells, PLoS One, 6, e23667, 10.1371/journal.pone.0023667 · DOI
  39. Mauritz, 2011, Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction, Eur Heart J, 32, 2634, 10.1093/eurheartj/ehr166 · DOI
  40. Dai, 2011, Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function, J Am Coll Cardiol, 58, 2118, 10.1016/j.jacc.2011.06.062 · doi:10.1016/j.jacc.2011.06.062
  41. Huang, 2013, Molecular strategy to reduce in vivo collagen barrier promotes entry of NCX1 positive inducible pluripotent stem cells (iPSC(NCX1+)) into ischemic (or injured) myocardium, PLoS One, 8, e70023, 10.1371/journal.pone.0070023 · DOI
  42. Botham, 2013, Clinical trials of adult stem cell therapy for peripheral artery disease, Methodist Debakey Cardiovasc J, 9, 201, 10.14797/mdcj-9-4-201 · DOI
  43. Cooke, 2015, Modulating the vascular response to limb ischemia: angiogenic and cell therapies, Circ Res, 116, 1561, 10.1161/CIRCRESAHA.115.303565 · DOI · Paper page
  44. Perin, 2014, Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells, Am Heart J, 168, 667, 10.1016/j.ahj.2014.07.021 · doi:10.1016/j.ahj.2014.07.021
  45. Spinetti, 2008, Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies, Cardiovasc Res, 78, 265, 10.1093/cvr/cvn039 · DOI · Paper page
  46. Asahara, 2004, Endothelial progenitor cells for postnatal vasculogenesis, Am J Physiol Cell Physiol, 287, C572, 10.1152/ajpcell.00330.2003 · DOI · Paper page
  47. Clayton, 2015, Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis, Int J Cardiol, 197, 116, 10.1016/j.ijcard.2015.06.038 · DOI
  48. Choi, 2009, Hematopoietic and endothelial differentiation of human induced pluripotent stem cells, Stem Cells, 27, 559, 10.1634/stemcells.2008-0922 · doi:10.1634/stemcells.2008-0922 · Paper page
  49. Taura, 2009, Induction and isolation of vascular cells from human induced pluripotent stem cells—brief report, Arterioscler Thromb Vasc Biol, 29, 1100, 10.1161/ATVBAHA.108.182162 · DOI · Paper page
  50. Lai, 2013, Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells, PLoS One, 8, e57876, 10.1371/journal.pone.0057876 · DOI
  51. Wang, 2014, Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds, Biomaterials, 35, 8960, 10.1016/j.biomaterials.2014.07.011 · DOI
  52. Hendry, 2008, Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells, J Thorac Cardiovasc Surg, 136, 1028, 10.1016/j.jtcvs.2007.12.053 · DOI
  53. Hung, 2008, Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction, Circ Cardiovasc Imaging, 1, 6, 10.1161/CIRCIMAGING.108.767343 · DOI
  54. Terrovitis, 2008, Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart, Circulation, 117, 1555, 10.1161/CIRCULATIONAHA.107.732073 · DOI · Paper page
  55. Sanganalmath, 2013, Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions, Circ Res, 113, 810, 10.1161/CIRCRESAHA.113.300219 · DOI · Paper page
  56. Li, 2009, Imaging survival and function of transplanted cardiac resident stem cells, J Am Coll Cardiol, 53, 1229, 10.1016/j.jacc.2008.12.036 · DOI · Paper page
  57. Keith, 2015, “String theory” of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results, Circ Res, 116, 1216, 10.1161/CIRCRESAHA.116.305557 · DOI
  58. Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587 · DOI · Paper page
  59. Quaini, 2002, Chimerism of the transplanted heart, N Engl J Med, 346, 5, 10.1056/NEJMoa012081 · DOI · Paper page
  60. Beltrami, 2001, Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, 1750, 10.1056/NEJM200106073442303 · DOI · Paper page
  61. Kajstura, 1998, Myocyte proliferation in end-stage cardiac failure in humans, Proc Natl Acad Sci U S A, 95, 8801, 10.1073/pnas.95.15.8801 · DOI · Paper page
  62. Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
  63. Messina, 2004, Isolation and expansion of adult cardiac stem cells from human and murine heart, Circ Res, 95, 911, 10.1161/01.RES.0000147315.71699.51 · DOI · Paper page
  64. Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
  65. van Berlo, 2014, c-kit+ cells minimally contribute cardiomyocytes to the heart, Nature, 509, 337, 10.1038/nature13309 · DOI · Paper page
  66. Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 · DOI · Paper page
  67. Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221 · DOI · Paper page
  68. Huang, 2010, Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion, Arterioscler Thromb Vasc Biol, 30, 984, 10.1161/ATVBAHA.110.202796 · DOI
  69. Hussein, 2011, Copy number variation and selection during reprogramming to pluripotency, Nature, 471, 58, 10.1038/nature09871 · DOI · Paper page
  70. Lister, 2011, Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, 471, 68, 10.1038/nature09798 · DOI · Paper page
  71. Li, 2015, Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse, PLoS One, 10, e0120585, 10.1371/journal.pone.0120585 · DOI
  72. Cyranoski, 2013, Stem cells cruise to clinic, Nature, 494, 413, 10.1038/494413a · DOI
  73. Kim, 2010, Epigenetic memory in induced pluripotent stem cells, Nature, 467, 285, 10.1038/nature09342 · DOI · Paper page
  74. Robinton, 2012, The promise of induced pluripotent stem cells in research and therapy, Nature, 481, 295, 10.1038/nature10761 · DOI · Paper page
  75. Nakagawa, 2008, Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts, Nat Biotechnol, 26, 101, 10.1038/nbt1374 · DOI · Paper page
  76. Schlaeger, 2015, A comparison of non-integrating reprogramming methods, Nat Biotechnol, 33, 58, 10.1038/nbt.3070 · DOI · Paper page
  77. Uosaki, 2011, Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression, PLoS One, 6, e23657, 10.1371/journal.pone.0023657 · DOI · Paper page
  78. Lian, 2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions, Nat Protocols, 8, 162, 10.1038/nprot.2012.150 · DOI · Paper page
  79. Fuerstenau-Sharp, 2015, Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells, PLoS One, 10, e0126596, 10.1371/journal.pone.0126596 · DOI
  80. Rufaihah, 2013, Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity, Am J Transl Res, 5, 21
  81. Ribeiro, 2015, Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness, Proc Natl Acad Sci U S A, 112, 12705, 10.1073/pnas.1508073112 · DOI · Paper page
  82. Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
  83. de Almeida, 2014, Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance, Nat Commun, 5, 3903, 10.1038/ncomms4903 · DOI · Paper page
  84. Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 · DOI · Paper page
  85. Okita, 2011, A more efficient method to generate integration-free human iPS cells, Nat Methods, 8, 409, 10.1038/nmeth.1591 · DOI · Paper page
  86. Gourraud, 2012, The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines, Stem Cells, 30, 180, 10.1002/stem.772 · DOI · Paper page
  87. Tsuji, 2010, Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury, Proc Natl Acad Sci U S A, 107, 12704, 10.1073/pnas.0910106107 · DOI · Paper page
  88. Takemoto, 2000, Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation, N Engl J Med, 343, 1078, 10.1056/NEJM200010123431504 · DOI · Paper page
  89. Lee, 2013, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, Nat Med, 19, 998, 10.1038/nm.3267 · DOI · Paper page
  90. Ban, 2011, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci U S A, 108, 14234, 10.1073/pnas.1103509108 · DOI · Paper page
  91. Simpson, 2014, Engineering patient-specific valves using stem cells generated from skin biopsy specimens, Ann Thorac Surg, 98, 947, 10.1016/j.athoracsur.2014.04.075 · doi:10.1016/j.athoracsur.2014.04.075
  92. Parker, 1980, “Transdifferentiation” of C6 glial cells in culture, Science, 208, 179, 10.1126/science.6102413 · DOI · Paper page
  93. Qian, 2012, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, Nature, 485, 593, 10.1038/nature11044 · DOI · Paper page
  94. Song, 2012, Heart repair by reprogramming non-myocytes with cardiac transcription factors, Nature, 485, 599, 10.1038/nature11139 · DOI · Paper page
  95. Srivastava, 2015, Recent advances in direct cardiac reprogramming, Curr Opin Genet Dev, 34, 77, 10.1016/j.gde.2015.09.004 · DOI
  96. Yoshida, 2012, Labor pains of new technology: direct cardiac reprogramming, Circ Res, 111, 3, 10.1161/CIRCRESAHA.112.271445 · DOI
  97. Margariti, 2012, Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels, Proc Natl Acad Sci U S A, 109, 13793, 10.1073/pnas.1205526109 · DOI · Paper page
  98. Lee, 2012, Activation of innate immunity is required for efficient nuclear reprogramming, Cell, 151, 547, 10.1016/j.cell.2012.09.034 · DOI · Paper page
  99. Sayed, 2015, Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity, Circulation, 131, 300, 10.1161/CIRCULATIONAHA.113.007394 · DOI · Paper page
  100. Bhatia, 2014, Microfluidic organs-on-chips, Nat Biotechnol, 32, 760, 10.1038/nbt.2989 · DOI · Paper page
  101. Jiang, 2014, An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes, Stem Cells Transl Med, 3, 416, 10.5966/sctm.2013-0105 · DOI
  102. Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat Chem Biol, 9, 232, 10.1038/nchembio.1199 · DOI · Paper page
  103. Lee, 2012, Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression, Nat Biotechnol, 30, 1244, 10.1038/nbt.2435 · DOI · Paper page
  104. Guo, 2013, Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model, Toxicol Sci, 136, 581, 10.1093/toxsci/kft205 · DOI
  105. Navarrete, 2013, Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays, Circulation, 128, S3
  106. Takayama, 2014, Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes, Proc Natl Acad Sci U S A, 111, 16772, 10.1073/pnas.1413481111 · DOI · Paper page
  107. Adams, 2013, Functional vascular endothelium derived from human induced pluripotent stem cells, Stem Cell Reports, 1, 105, 10.1016/j.stemcr.2013.06.007 · DOI · Paper page
  108. Soldner, 2012, iPSC disease modeling, Science, 338, 1155, 10.1126/science.1227682 · DOI · Paper page
  109. Psaltis, 2006, Developing optofluidic technology through the fusion of microfluidics and optics, Nature, 442, 381, 10.1038/nature05060 · DOI · Paper page
  110. Kim, 2011, High-throughput single-molecule optofluidic analysis, Nat Methods, 8, 242, 10.1038/nmeth.1569 · DOI
  111. Agarwal, 2013, Microfluidic heart on a chip for higher throughput pharmacological studies, Lab Chip, 13, 3599, 10.1039/c3lc50350j · DOI · Paper page
  112. Grosberg, 2011, Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip, Lab Chip, 11, 4165, 10.1039/c1lc20557a · DOI · Paper page
  113. Ge, 2012, Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells, Circulation, 126, 1695, 10.1161/CIRCULATIONAHA.112.116996 · DOI
  114. Asimaki, 2014, Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy, Sci Transl Med, 6, 240ra74, 10.1126/scitranslmed.3008008 · DOI · Paper page
  115. Ma, 2013, Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 34, 1122, 10.1093/eurheartj/ehs226 · DOI · Paper page
  116. Kim, 2013, Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs, Nature, 494, 105, 10.1038/nature11799 · DOI · Paper page
  117. Lan, 2013, Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells, Cell Stem Cell, 12, 101, 10.1016/j.stem.2012.10.010 · DOI · Paper page
  118. Hick, 2013, Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia, Dis Model Mech, 6, 608
  119. Huang, 2011, Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification, Hum Mol Genet, 20, 4851, 10.1093/hmg/ddr424 · DOI
  120. Kujala, 2012, Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations, PLoS One, 7, e44660, 10.1371/journal.pone.0044660 · DOI
  121. Jung, 2012, Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia, EMBO Mol Med, 4, 180, 10.1002/emmm.201100194 · DOI · Paper page
  122. Novak, 2012, Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation, J Cell Mol Med, 16, 468, 10.1111/j.1582-4934.2011.01476.x · DOI · Paper page
  123. Itzhaki, 2012, Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells, J Am Coll Cardiol, 60, 990, 10.1016/j.jacc.2012.02.066 · DOI · Paper page
  124. Lahti, 2012, Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture, Dis Model Mech, 5, 220, 10.1242/dmm.008409 · DOI · Paper page
  125. Yazawa, 2011, Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome, Nature, 471, 230, 10.1038/nature09855 · DOI · Paper page

Cited by

See all 50

Metadata

Authors
Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C.
Venue
JACC: Basic to Translational Science
Publisher
Elsevier BV
Published
2016-10
Volume
1
Issue
6
Pages
510-523
ISSN
2452-302X
Cited by
50
References
17
Language
en
Licence
Funders
  • National Center for Advancing Translational Sciences (UL1-TR001427, 1R01 HL125224)
  • National Institutes of Health (HL-78825, 1T32HL098049-01A1)
  • National Heart, Lung, and Blood Institute (5UM1 HL113456-02, UM1-HL113530, 5UM1-HL087366-07)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. https://app.cochat.ai/papers/10.1016/j.jacbts.2016.06.010
The paper
Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C. (2016). The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. JACC: Basic to Translational Science. https://doi.org/10.1016/j.jacbts.2016.06.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.